Skip to main content
Photo of  Bryan C. Hambley, MD, MPH

Bryan C. Hambley, MD, MPH

Assistant Professor of Clinical

Internal Medicine | College of Medicine

Education/Credentials
  • Fellowship: Johns Hopkins Hospital
  • Fellowship: Johns Hopkins Hospital
  • Fellowship: Case Western Reserve University
  • Chief Resident: Case Western Reserve University
  • Internship: Case Western Reserve University
  • Master's Degree: Tulane University School of Public Health
  • Medical Degree: Tulane University School of Medicine
  • Bachelor's Degree: University of Notre Dame
Board Certifications & Licenses

American Board of Internal Medicine (Critical Care Medicine) (Certification Date: 20201215)
American Board of Internal Medicine (Hematology) (Certification Date: 20191025)
American Board of Internal Medicine (Certification Date: 20150811)

Specialties

Critical Care Medicine
Hematology
Internal Medicine

Contact Information

Clinical Interests

Critical Care Medicine

Hematology and Oncology

Leukemia

Acute Lymphocytic Leukemia

Acute Myeloid Leukemia

Amyloidosis

Castleman Disease

Chronic Lymphocytic Leukemia

Chronic Myelogenous Leukemia

Lymphadenopathy

Lymphoma

M Protein

Macrocytosis

Mediastinal Adenopathy

Monoclonal gammopathy

Monoclonal protein

Mycosis Fugoides

Myelodysplastic Syndrome

Myeloma

Myeloproliferative Disorder

Paraproteinemia

Plasma Cell Disorder

Plasminogen Activator Inhibitor 1

Polycythemia vera

Proteinuria

Sideroblastic anemia

T-cell lymphoma

M-Spike

Peer Reviewed Publications

Alex Ambinder, Bryan Hambley, Satish Shanbhag, and Sam Merrill 2019. Ibrutinib-associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins American Journal of Hematology, ,

Bryan Hambley, Kelly Norsworthy, Jagar Jasem, Jacquelyn Zimmerman et al. 2019. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction Leukemia Research, ,

Eric Gehrie et al. 2019. One-unit compared to two-unit platelet transfusions for adult oncology outpatients Vox Sanguinis, ,

Bryan Hambley, Paolo Caimi, and Basem William 2016. Bortezomib for the treatment of mantle cell lymphoma: an update Therapeutic Advances in Hematology, ,